Basic Surgery Training Platform Scores $20 Million

Headquarters in London BasicVRmaker of a virtual reality surgery training platform, announced last week that it has raised $20 million in Series B funding.

The round was led by EQT Life Sciences and involved former investor Downing Ventures.

The most recent basicVR close $5 million Series A in 2019. The latest funding round brings the startup’s total funding to over $30 million.


The company’s Basic Surgery program allows surgeons and trainees to practice procedures in a virtual reality environment. Its tools include HapticVR, a method that uses a handheld device or glove to generate physical feedback, as well as group learning feature and a home system Can be used on standalone VR headset.

Fund BasicVR says the Series B investment will be used to further develop HapticVR and its machine learning data analytics product and enable geographic expansion in the US.

“Our platform can conduct procedure instruction until full operation, facilitating the transfer of surgical skills – that’s why we’re so well received in the industry. across the healthcare industry, from medical device manufacturers to pharmaceuticals,” said CEO and co-founder Richard Vincent in the statement. “Our immersive environment transforms the acquisition of surgical skills in a scalable, low-cost, multi-user way. We are excited to expand our vision of creating an environment that is truly immersive. medical education is not impeded by borders.”


Another healthcare VR training company is Sydney-based Vantari VR, which late last year announced right heart catheterization training program.

The Japanese company Jolly Good is another company in this field. It is expanding to other uses for this method, including VR . therapy research for chronic pain. Earlier this year, Jolly Good signed a deal worth more than 40 million dollars with Otsuka Pharmaceutical to expand the use of VR social skills training in the treatment of mental health conditions in Japan.

AppliedVR is also using VR to improve pain. At the end of last year, it increased $36 million in Series B funding and received FDA De Novo . license its systemic use for the treatment of chronic low back pain.

XRHealth, which also introduced its VR tools for behavioral health and pain conditions, announced that it has obtained 10 million dollars in funding this early year.

Source link


Kig News: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button